Pulmonary embolism can be treated without admission to the hospital

In recent years, a number of methods for determining the risk of serious complications and mortality in pulmonary embolism, which help patients should be identified with a low risk of developing complications. Such patients can given outpatient treatment, hospital stay in the hospital will be optional. The most reliable method for the diagnosis of pulmonary embolism severity index (PESI), on 11 simple and well-defined criteria, reports In a recent study of 599 patients with pulmonary embolism, 36% of patients with PESI MediSwiss.Ru has been identified as a risk insignificant, with the possible mortality of 0.9% in 30 days (negative predictions - 99.1%). Even for severe complications (bleeding increased thromboembolic recurrences) PESI negative forecasts were very good (97.2%). So PESI fairly simple and well-defined predictor for patients to isolate with a low risk of unfavorable development of the disease, an outpatient or short stay in the hospital. Today ambulatory treatment of varicose veins and deep vein thrombosis include in the recommendation by many leading organizations such as the British Thoracic Society (British Thoracic Society) and the American College of Physicians on the Diseases of the Chest (American College of Chest Physicians). Venous thromboembolic disease, ie, deep vein thrombosis and / or pulmonary embolism is one of the most common diseases that can lead to death. And it is defined as a pulmonary embolism without hypotension and without severe respiratory failure - outpatient LMWH very reliable and efficient Recent studies that some patients showed nonmassive with pulmonary embolism. Based on these results, the British Thoracic Society and the American College of Physicians on the diseases of the chest for carefully selected patients with pulmonary embolism nonmassive outpatient treatment with low molecular weight heparin is recommended. Despite the numerous advantages (stay better quality of life, greater physical and social activity, reduced hospital costs and lower) nonmassive pulmonary embolism rarely treated on an outpatient basis. Until now, no study to compare the clinical course nonmassive pulmonary embolism in hospitalized patients and those who received outpatient treatment. The recommendation that patients with ambulatory nonmassive embolism treatment is largely based on research with a small number of cases. Example with deep vein thrombosis shows that the reliability of the method are first backed by clinical trials, and only then, doctors could go to outpatient treatment nonmassive pulmonary embolism. Study, the reliability and validity of ambulatory patients with a low risk test for PESI, is currently carried out in Switzerland and other countries.